The company has received fifteen new orders from central or state government agencies in the month of December 2020.

According to the contract, the company is set to supply and install an ultra-converged broadband product.

Additionally, the company has also received tentative approval for Apremilast tablets. 

Saroglitazar Mg is the first medicine used for the treatment of NAFLD. This approval for NAFLD, along with either of the co-morbidities (obesity, type 2 Diabetes Mellitus, Dyslipidemia) would provide physicians with a viable treatment option.  

The launch of Tacrolimus capsules expands Biocon’s generic formulation portfolio in the US. 

Moreover, the company will provide an enhanced full-service enterprise mobility solution to customers through complete access and management of eSIM & software layer. 

Under this agreement, Glenmark Pharma will be responsible for the development & regulatory approval of the nasal spray by relevant European Regulatory Authorities whereas, Menarini Group will be responsible for the commercialisation of Ryaltris across these markets. 

With this strategic acquisition, Firstsource Solutions will be able to strengthen its presence in large markets like Texas and New York, coupled with new capabilities of pre-authorisation and patient bill estimation at the front-end of the RCM cycle.  

The EPC project is regarding the construction of eight-lane access-controlled expressway in the section of Delhi-Vadodara greenfield alignment under Bharatmala Pariyojana in the state of Rajasthan.

The civil engineering company will construct an elevated viaduct of 11.6 km from Kadarshani Nal (Gujarat) to Dream City Dead End for Surat Metro Rail Project Phase-1.  The project is worth Rs 779.73 crore with a construction period of 30 months.